Related references
Note: Only part of the references are listed.Safety and Effectiveness of an All-Oral, Bedaquiline-Based, Shorter Treatment Regimen for Rifampicin-Resistant Tuberculosis in High Human Immunodeficiency Virus (HIV) Burden Rural South Africa: A Retrospective Cohort Analysis
Ilse Tack et al.
CLINICAL INFECTIOUS DISEASES (2021)
World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
Fuad Mirzayev et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Insignificant difference in culture conversion between bedaquiline-containing and bedaquiline-free all-oral short regimens for multidrug-resistant tuberculosis
Liang Fu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
Richard Court et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019-2020
Teona Avaliani et al.
MONALDI ARCHIVES FOR CHEST DISEASE (2021)
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Francesca Conradie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
Andrew J. Nunn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
Sergey Borisov et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs
A. Van Deun et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2018)
The Fourth National Anti-Tuberculosis Drug Resistance Survey in Viet Nam
N. V. Nhung et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients
K. J. M. Aung et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience
S. Hoffner et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)